Tamer Group is a leading healthcare, beauty care, prestige products, and fast moving consumer goods company responding to the growing needs of the Saudi and Middle East communities. The Group’s core activities are import, distribution, promotion, marketing and manufacturing. Today, Tamer Group has established a special position in the Saudi marketplace, resulting from a unique approach to business, service and customer portfolio.
Tamer Group Established in 1922 Tamer Group has been pioneers in bringing modern medicines to Saudi Arabia for over 94 years with annual turnover exceeds $ 1.3 billion. Nowadays is a leading supplier of healthcare products in the MENA region. Its cover the import, marketing and distribution of pharmaceuticals, medical equipment and supplies. Its manufacturing arm “SAJA” produces the latest researched products as well as generics for the MENA, The Group handles the promotion and distribution of a wide range of pharmaceutical products including ethical products, herbal and food supplements.
Astellas is a global pharmaceutical company with corporate
origins in Japan
Astellas engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation, immunology, infectious diseases, urology, oncology, neuroscience, diabetic complications, and metabolic diseases.
Astellas aims to stand on the forefront of healthcare change, turning innovative science into value for patients and will continually strive to fulfill the expectations of our stakeholders and society.
Daiichi Sankyo is a global pharmaceutical company with
corporate origins in Japan.
Daiichi Sankyo innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
Daiichi Sankyo aim to contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs.